Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects.

about

Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects.

Item

http://www.wikidata.org/entity/Q40121090

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects.

@en

type

Item

label

Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects.

@en

prefLabel

Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects.

@en

P1476

Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects.

@en

P2093

David P Nicolau

http://www.w3.org/2001/XMLSchema#string

Dimitrios K Matthaiou

http://www.w3.org/2001/XMLSchema#string

George Dimopoulos

http://www.w3.org/2001/XMLSchema#string

Georgios Siakallis

http://www.w3.org/2001/XMLSchema#string

P2860

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient

The use of inhaled antibiotic therapy in the treatment of ventilator-associated pneumonia and tracheobronchitis: a systematic review

Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis

Inhaled Antibiotics for Gram-Negative Respiratory Infections

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections.

Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia.

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial.

Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial.

P2888

s40265-017-0787-0

P304

1399-1412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-017-0787-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Garyphallia Poulakou

P577

2017-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090877804

http://www.w3.org/2001/XMLSchema#string

P698

28741229

http://www.w3.org/2001/XMLSchema#string

P921

Bruschtfiewer

ventilator